INDIVIDUALIZED DOSING OF HYDROXYUREA FOR CHILDREN WITH SICKLE CELL ANEMIA USING A PHARMACOKINETIC-BASED MODEL; THE TREAT STUDY.

被引:0
|
作者
McGann, P. T. [1 ]
Dong, M. [1 ]
Mizuno, T. [1 ]
Marahatta, A. [1 ]
Ware, R. E. [1 ]
Vinks, A. A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII-093
引用
收藏
页码:S77 / S78
页数:2
相关论文
共 50 条
  • [1] Individualized Dosing of Hydroxyurea for Children with Sickle Cell Anemia Using a Population Pharmacokinetic-Based Model: The TREAT Study
    McGann, Patrick T.
    Dong, Min
    Marahatta, Anu
    Howard, Thad A.
    Mizuno, Tomoyuki
    Kalinyak, Karen A.
    Kalfa, Theodosia A.
    Malik, Punam
    Niss, Omar
    Quinn, Charles T.
    Ware, Russell E.
    Vinks, Alexander A.
    BLOOD, 2016, 128 (22)
  • [2] Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia
    McGann, Patrick T.
    Dong, Min
    Ware, Russell E.
    Vinks, Alexander A.
    BLOOD, 2015, 126 (23)
  • [3] Intensive hydroxyurea dosing in very young children with sickle cell anemia
    Wang, Winfred C.
    Brown, R. Clark
    Mcnaull, Melissa A.
    Rogers, Zora R.
    Barton, Martha
    Dua, Meghna R.
    Hankins, Jane S.
    Gossett, Jeffrey
    Richardson, Julie
    Porter, Jerlym S.
    Kang, Guolian
    Estepp, Jeremie H.
    BLOOD ADVANCES, 2023, 7 (22) : 6931 - 6935
  • [4] Clinical and Laboratory Benefits of Early Initiation of Hydroxyurea with Pharmacokinetic Guided Dosing for Young Children with Sickle Cell Anemia
    McGann, Patrick T.
    Niss, Omar
    Dong, Min
    Marahatta, Anu
    Mizuno, Tomoyuki
    Kalinyak, Karen
    Kalfa, Theodosia A.
    Malik, Punam
    Quinn, Charles T.
    Ware, Russell E.
    Vinks, Alexander A.
    BLOOD, 2018, 132
  • [5] Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study
    John, Chandy C.
    Opoka, Robert
    Latham, Teresa
    Hume, Heather
    Nakafeero, Maria
    Kasirye, Phillip
    Ndugwa, Christopher
    Lane, Adam
    Ware, Russell E.
    BLOOD, 2019, 134
  • [6] THE FEASIBILITY OF PHARMACOKINETIC-GUIDED HYDROXYUREA DOSING FOR CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA: ANALYSIS OF THE ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT) TRIAL
    Power-Hays, A.
    Namazzi, R.
    Kazinga, C.
    Mufumba, I.
    Latham, T.
    Conroy, A.
    Opoka, R.
    Vinks, A.
    Dong, M.
    Ware, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S58 - S58
  • [7] Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial
    Power-Hays, Alexandra
    Namazzi, Ruth
    Kato, Charles
    Mcelhinney, Kathryn E.
    Conroy, Andrea L.
    Hume, Heather
    John, Chandy
    O'Hara, Sara M.
    Stuber, Susan E.
    Lane, Adam
    Latham, Teresa S.
    Opoka, Robert O.
    Ware, Russell E.
    ACTA HAEMATOLOGICA, 2024,
  • [8] Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia
    McGann, Patrick T.
    Niss, Omar
    Dong, Min
    Marahatta, Anu
    Howard, Thad A.
    Mizuno, Tomoyuki
    Lane, Adam
    Kalfa, Theodosia A.
    Malik, Punam
    Quinn, Charles T.
    Ware, Russell E.
    Vinks, Alexander A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) : 871 - 879
  • [9] Hydroxyurea Dosing in Very Young Children with Sickle Cell Anemia: A Multicenter, Randomized, Controlled Trial (HUGKISS)
    Dua, Meghna
    Wang, Winfred C.
    Brown, R. Clark
    McNaull, Melissa A.
    Rogers, Zora R.
    Barton, Martha
    Hankins, Jane
    Gossett, Jeffrey
    Richardson, Julie
    Porter, Jerlym S.
    Kang, Guolian
    Estepp, Jeremie H.
    BLOOD, 2022, 140
  • [10] Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia
    Power-Hays, Alexandra
    Dong, Min
    Punt, Nieko
    Mizuno, Tomoyuki
    Smart, Luke R.
    Vinks, Alexander A.
    Ware, Russell E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) : 670 - 677